The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Background: Lung cancer is a well-known comorbidity of interstitial lung disease (ILD), and the actual efficacy and safety of chemotherapy for patients with non-small cell lung cancer and interstitial lung disease (NSCLC-ILD) have not been determined. We conducted this meta-analysis to assess the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanning, Miao, Liyun, Hu, Yuxuan, Zhou, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506119/
https://www.ncbi.nlm.nih.gov/pubmed/33014824
http://dx.doi.org/10.3389/fonc.2020.01636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506119/
https://www.ncbi.nlm.nih.gov/pubmed/33014824
http://dx.doi.org/10.3389/fonc.2020.01636

Ejemplares similares